Inflammatory mediators and immune response in Mexican adolescents;Mediadoresinflamatorios y respuesta inmunitaria en adolescentes Mexicanos

Nutricion Hospitalaria

Volumn 26, Issue 5, 2011, Pages 1115-1119

  Pardo Morales, R V ^a   Zuniga Torres M G ^a   Martinez Carrillo B E ^a   Gomez Martinez S ^b   Marcos, A ^b   Valdes Ramos R ^a  

^a UNIVERSIDAD AUTÓNOMA DEL ESTADO DE MÉXICO   (Mexico)

^b CSIC   (Spain)

Author keywords

Adolescents; Immunity; Inflammation; Overweight

Indexed keywords

AUTACOID; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ARTICLE; BLOOD; BODY MASS; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNITY; IMMUNOLOGY; MALE; MEXICO; OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY; SAMPLE SIZE; SEX DIFFERENCE; URBAN POPULATION;

ADOLESCENT; BODY MASS INDEX; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNITY; INFLAMMATION MEDIATORS; INTERLEUKIN-6; MALE; MEXICO; OVERWEIGHT; SAMPLE SIZE; SEX FACTORS; TUMOR NECROSIS FACTOR-ALPHA; URBAN POPULATION;

EID: 80052739210     PISSN: 02121611     EISSN: 16995198     Source Type: Journal    
DOI: 10.3305/nh.2011.26.5.5166     Document Type: Article

References (27)

1. López-Jaramillo P. Enfermedades cardiometabólicas en Ibero-américa: papel de la programación fetal en respuesta a la desnutrición materna. Rev Esp Cardiol 2009; 62 (6): 670-6.
2. Muñoz M, Mazure RA, Culebras JM. Obesidad y sistema inmune. Nutr Hasp 2004; 319-24.
3. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006; 444: 860-7.
4. Gustafson B, Hammarstedt A, Anderson CX, Smith U. Inflamed adipose tissue: a culprit underlying the metabolic syndrome and atherosclerosis. Arterioscler Thromb Vase Biol 2007;27:2276-83.
5. Wärnberg J, Marcos A. Low-grade inflammation and the metabolic syndrome in children and adolescents. Curr Opin Lipidol 2008; 19: 11-5.
6. Wärnberg J, Nova E, Moreno LA, et al. Inflammatory proteins are related to total and abdominal adiposity in a healthy adolescent population: the AVENA Study. Am J Clin Nutr 2006; 84: 505-12.
7. González-Gross M, Castillo MJ, Moreno L et al. Alimentatión y valoración del estado nutricional de los adolescentes españoles (Estudio AVENA). Evaluacion deriesgos y propuesta de intervention I. Descriptión metodológica del proyecto. Nutr Hasp 2003; 18(1): 15-28.
8. Lohman TG, Roche AF, Martorell R. Anthropometric standardization reference manual. Abridged edition. Champaign, 111, USA: Human Kinetics Books; 1991.
9. Kuczmarski RJ, Ogden CL, Guo SS, et al. 2000 CDC growth charts for the United States: Methods and development. National Center for Health Statistics. Vital Health Stat 11(246). 2002.
10. Jolliff CR, Cost DM, Stivrings PC, Grossman PP, Nolte CR, Franco SM et al. Reference intervals for serum IgA, IgM, C3 and C4 as determined by rate nephelometry. Clin Chern 1982; 28(1): 126-8.
11. Rodríguez-Caballero A, García-Montero AC, Bueno C, Almeida J, Varro R, Chen R et al. A new simple whole blood flow cytometry-based method for simultaneous identification of activated cells and quantitative evaluation of cytokines released during activation. Lab Invest 2004; 84: 1387-98.
12. Ritchie RF, Palomaki GE, Neveux LM, Navolotskaia O, Ledue TB, Craig WY. Reference distributions for complement proteins C3 and C4: a practical, simple and clinically relevant approach in a large cohort. J Clin Lab Anal 2004; 18:1-8.
13. Moshage H. Cytokines and hepatic acute phase response. J Pathol 1997; 181:257-66.
14. Wärberg J, Moreno LA, Mesana MI, Marcos A, AVENA Group. Inflammatory mediators in overweigth and obese Spanish adolescents. The AVENA Study. Int J Obes 2004; 28: S59-63.
15. Soria-Villa R, Reyna-Figueroa J, Lara-Sánchez J, Cérbulo-Vázquez A, Ortiz-Ibarra FJ. Evaluacion de los valores de inmu-noglobulinas y de complemento en una población de recien nacidos sanos mexicanos. Revista de Enfermedades Infecciosas en Pediatría 2005; 43 (73).
16. Yilmazer M, Fenkci V, Fenkci S, Aktepe O, Sonmezer M, Kurtay G. Association of serum complement (C3,C4) and immunoglobulin (IgG,IgM) levels with hormone replacement therapy in healthy post-menopausal women. Hum Reprod 2003; 18(7): 1531-5.
17. Carranza S, Mac Gregor AL, Olivares A, González SL, Saldivar N, Martínez JC. Modificatión de las concentra-ciones de C3 y C4 luego de la administratión de estrogenos conjugados más medroxiprogesterona o raloxifeno en mujeres posmenopáusicas. Ginecol Obstet Mex 2005; 73: 521-4.
18. Warnberg J. Inflammatory Status in Adolescents; The Impact of Health Determinants such as Overweight and Fitness [dissertation]. Karolinska Institutet Stockholm, 2006.
19. Acevedo M, Arnaiz P, Barja S, Bambs C, Berríos X, Guzmán B et al. Proteína C reactiva y su relatión con adipocidad, factores de riesgo cardiovascular y atero sclera sis subclínica en niños sanos. Rev Esp Cardiol 2001; 60 (10): 1051-8.
20. Bradley JR. TNF-mediated inflammatory disease. J Pathol 2008; 214: 149-60.
21. Zulet MA, Puchau B, Navarro C, Martí A, Martínez JA. Biomarcadores del estado inflamatorio: nexo de union con la obesidad y complicaciones asociadas. Nutr Hosp 2007; 22 (5): 511-27.
22. Aeckerman LS. Sex hormones and the genesis of autoimmunity. Arch Dermatol 2006; 142: 371-6.
23. León-Nava MA, Morales-Montor J. Dimorfismo sexual inmu-nitario: ¿pueden los esteroides sexuales polarizar el perfil de citocinas Thl/Th2? Rev Invest Clin 2006; 58 (2): 161-9.
24. RK. Nutrition and the immune system: an introduction. Am J Clin Nutr 1997; 66:460S-63S.
25. Lamas O, Marti A, Martínez JA. Obesity and inmunocompe-tence. Eur J Clin Nutr 2002; 56 (Suppl. 3): S42-45.
26. Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, et al. Recent advances in the relationship between obesity, inflammation, and insulin resistence. Eur Cytokine Netw 2006; 17(1): 4-12.
27. Slobodianik NH. Obesity and defense mechanisms. Actualizatión en Nutricion 2007; 8 (3): 200-2.